Form 8-K Valeant Pharmaceuticals For: Mar 15

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 10/9/2026

1. SPCX
2. LEVI
3. SBUX
4. NVDA
5. GOOGL

6. AAPL
7. SPY
8. APLD
9. ORCL
10. USO

Valeant Pharma (VRX) Results Suggest Disruption in the Business - Evecore ISI's Raffat

March 15, 2016 10:56 AM EDT

Evercore ISI analyst, Umer Raffat, commented on Valeant Pharma (NYSE: VRX) after the call.

"I think it will be an understatement to say that this has clearly been a very humbling call for me," he said.

".. today's results suggests that while... More

Valeant Pharma (VRX) Conference Call Ends

March 15, 2016 10:13 AM EDT

Valeant Pharma (NYSE: VRX) brutal conference call ends. With shares down 36.7% traders will be looking for the stock to possibly rally later in the session.

... More

Valeant Pharma (VRX) Misses Dramatically Reduced Expectations - BMO

March 15, 2016 9:00 AM EDT

BMO Capital analyst, Alex Arfaei, posted an earnings flash on Valeant Pharmaceuticals' (NYSE: VRX) miss and guide down. The call is ongoing and began at 8:00AM.

This morning, Valeant reported unaudited 4Q15 revenues of $2.78B, 1% above consensus of $2.75B. Gross margin of 75.6%... More

The Single Most Important Catalyst for Valeant Pharma (VRX) Near-Term...

March 15, 2016 8:15 AM EDT

Valeant Pharma (NYSE: VRX) is down 15% after posting unaudited fourth quarter result and disappointing 2016 guidance. However, according to Evecore ISI analyst Umer Raffat, the single most important catalyst for Valeant near-term is timing for covenants/10-K filing to avoid default .

The all-important date of a default is March 30th + 30 days, so April 29.

Covenant... More

Valeant Pharma (VRX) Won't File 10-K Within 15-Day Extension Period

March 15, 2016 6:19 AM EDT

Valeant Pharma (NYSE: VRX) disclosed the following on Tuesday:

Item 2.02 Results of Operations and Financial Condition

On March 15, 2016, Valeant Pharmaceuticals International, Inc. (the Company) issued a press release announcing preliminary unaudited financial results for the fourth quarter ended December 31, 2015. A copy of the press release is attached as Exhibit 99.1 to this report and is incorporated herein by reference.